CREDITACCESS GRAMEEN LIMITED has informed the Exchange regarding Outcome of Board Meeting held on May 16, 2025.

Results View source PDF Explain this filing

CREDITACC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-6.6%Reaction day

₹1200.00

prior close

₹1149.00

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.7%-7.3% vs market

Finance peers, median of 375sector · industry level+0.3%-6.8% vs sector

On the reaction day the stock moved 7.3 pts less than Nifty Smallcap 250 and 6.8 pts less than its Finance peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.5

15m

-0.8

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-6.6+0.7-7.3+0.3-6.8

Next day

-7.7-0.2-7.4-0.5-7.2

-8.3+0.2-8.5-0.0-8.3

-6.6+0.2-6.8-0.5-6.1

-7.1+0.8-7.9+0.0-7.1

-4.6+1.3-5.9+0.0-4.6

-0.9+1.8-2.7+0.4-1.3

15d

+0.3+6.8-6.4+1.7-1.4

-6.7+2.5-9.1-1.7-5.0

+7.3+9.0-1.7+1.4+5.9

+12.1+3.7+8.4-1.6+13.7

UpDownMarket · Nifty Smallcap 250Sector · Finance peers, median of 375Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

CreditAccess Grameen reported FY25 (consolidated/standalone broadly similar) revenue from operations of ₹5,752 crore, up about 11% from ₹5,167 crore in FY24, driven by higher interest income of ₹5,547 crore. However, net profit after tax collapsed to ₹531 crore from ₹1,446 crore in FY24, a drop of roughly 63%, mainly due to a more than 4x jump in impairment on financial instruments to ₹1,930 crore (from ₹452 crore). Q4 FY25 swung back to a small profit of ₹47 crore after a Q3 loss of ₹200 crore. The Board has not proposed any dividend for FY25, against ₹10 per share paid for FY24. Asset quality shows Gross Stage III at 4.76% and Net Stage III at 1.73%, with CRAR at a healthy 25.42% and debt-to-equity at 2.95.

Likely market impact

The sharp drop in profit on the back of sharply higher loan-loss provisions is a negative for short-term sentiment, but stable capital adequacy and contained NPAs suggest underlying franchise health. The dividend skip will disappoint income-focused shareholders.